Europe: LSP 6 closes at US$600m

René Kuijten, managing partner, LSP

Life sciences investor LSP has closed LSP 6 at a US$600m hard cap. This is the largest fund ever raised in Europe focused on life sciences ventures. “We thank our loyal investors for their continued trust in LSP. Our track record, our long standing in the industry, as well as our stable and experienced team…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »